Usability & Adherence: Key to Clinical and Commercial Success

A PARI inhaler and a smartphone displaying breathing instructions are overlaid with digital data, molecular structures, and abstract blue patterns.

The success of the inhaled therapy is highly dependent on correct device use, patient motivation and therapy adherence. eFlow® Technology nebulizers together with the PARI Connect Platform are designed to improve inhalation treatments. With a forward-looking approach our in-house human factors engineering team performs and supports usability studies.
 

Expert Interviews:

Hear from our experts regarding device usability and our digital solutions with the aim of increasing therapy adherence.

Usability

Martin Schlun, Director eFlow Development & Technology, shares insights on how we optimize the nebulizer usability and thus adherence.

Digital Solutions

Dr. Carola Fuchs, Director e-Health Solutions, talks about how we can add value to patients and ultimately to you as a partner with our digital solutions.

A hand holds a white and gray eFlow Integrated inhaler against a dark blue background.

State-of-the-art Nebulizer Usability

Discover how human factor studies shaped our new eFlow Integrated device platform from the very beginning to increase patient adherence.

How eFlow® Technology Enhances Patient Adherence in Clinical Studies and Commercialization

  • Reduced treatment time through short nebulization time
  • Patient-centric device design and easy assembly for increased acceptance
  • PARI Connect® App for better therapy outcomes – proven enhancement of therapy adherence as well as motivation of patients in day-to-day use


Want to Optimize Patient Adherence?

eFlow-partneringpari.com

PARI Business Development Team